List of insiders holdings for APPLIED GENETIC TECHNOLOGIES CORP:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Carroll Jill Director 10% Owner | 2014-04-01 16:29:10 | 0 1,989,598 | 1,989,598 | Form 4 |
MedImmune Ventures Inc. 10% Owner | 2014-04-01 16:29:48 | 1,464,092 0 | 1,464,092 | Form 4 |
Wu Samuel Director 10% Owner | 2014-04-01 16:31:49 | 0 1,464,092 | 1,464,092 | Form 4 |
INTERWEST PARTNERS VIII LP InterWest Management Partners VIII LLC INTERWEST INVESTORS VIII L P INTERWEST INVESTORS Q VIII LP GIANOS PHILIP T Kliman Gilbert H Holmes W Stephen CASH HARVEY B 10% Owner | 2022-02-14 06:17:31 | 1,414,515 0 | 1,414,515 | Form 13G |
Menichella Daniel L V.P. & Chief Business Officer | 2015-01-26 18:04:05 | 115,972 0 | 115,972 | Form 4 |
Heah Theresa Chief Medical Officer | 2019-07-31 20:51:34 | 100,000 0 | 100,000 | Form 4 |
Feinsod Matthew Exec. VP, Global Strat. & Dev. | 2019-07-31 20:28:19 | 100,000 0 | 100,000 | Form 4 |
Ashe Andrew D. General Counsel | 2017-08-03 18:18:58 | 100,000 0 | 100,000 | Form 4 |
Alta Partners VIII L.P. CHAMPSI FARAH JANNEY DANIEL NOHRA GUY P Alta Partners Management VIII LLC 10% Owner | 2018-05-31 16:55:23 | 51,896 0 | 51,896 | Form 13D |
Sullivan William A. Chief Financial Officer | 2020-08-07 20:11:59 | 50,000 0 | 50,000 | Form 4 |
Shearman Mark S Chief Scientific Officer | 2020-08-18 18:15:53 | 33,277 0 | 33,277 | Form 4 |
Goldstein Michael H. Chief Medical Officer | 2017-07-18 20:39:53 | 25,000 0 | 25,000 | Form 4 |
Chulay Jeffrey D. VP and Chief Medical Officer | 2016-11-02 18:42:09 | 20,400 0 | 20,400 | Form 4 |
Krol Patrick Johan Hendrik Stichting Aescap 2.0 Privium Fund Management B.V. Inspirational Visions B.V. 10% Owner | 2021-02-09 17:01:20 | 17,999 0 | 17,999 | Form 13G |
Magovcevic-Liebisch Ivana Director | 2021-12-02 18:55:13 | 14,000 0 | 14,000 | Form 4 |
Krex Brian General Counsel | 2019-08-19 20:07:07 | 13,000 0 | 13,000 | Form 4 |
ORONSKY ARNOLD L Director | 2017-04-26 13:07:05 | 0 11,208 | 11,208 | Form 4 |
Knop David R. Director, Process Development | 2014-08-04 18:42:32 | 7,648 0 | 7,648 | Form 4 |
PEACOCK BRUCE Director | 2015-12-04 16:34:15 | 6,200 0 | 6,200 | Form 4 |
BULLOCK LAWRENCE E Chief Financial Officer | 2017-08-09 21:54:14 | 4,168 0 | 4,168 | Form 4 |
Robinson James A. Jr. Director | 2022-12-01 09:23:47 | 0 0 | 0 | Form 4 |
VANLENT ANNE Director | 2022-12-01 09:23:04 | 0 0 | 0 | Form 4 |
Rosen James Director | 2022-12-01 09:22:27 | 0 0 | 0 | Form 4 |
Aliski William Director | 2022-12-01 09:21:19 | 0 0 | 0 | Form 4 |
HURWITZ EDWARD Director | 2022-12-01 09:19:33 | 0 0 | 0 | Form 4 |
Hashad Yehia Director | 2022-12-01 09:18:53 | 0 0 | 0 | Form 4 |
Koenig Scott Director | 2022-12-01 09:18:12 | 0 0 | 0 | Form 4 |
Scaria Abraham Chief Scientific Officer | 2022-12-01 09:16:28 | 0 0 | 0 | Form 4 |
Reynolds Gerald Anthony Chief Accounting Officer | 2022-12-01 09:16:52 | 0 0 | 0 | Form 4 |
DOyley-Gay Hope General Counsel | 2022-12-01 09:15:54 | 0 0 | 0 | Form 4 |
Potter Stephen W Chief Business Officer | 2022-12-01 09:16:12 | 0 0 | 0 | Form 4 |
Schneider Susan Chief Medical Officer | 2022-12-01 09:15:33 | 0 0 | 0 | Form 4 |
Lieber Jonathan I Chief Financial Officer | 2022-12-01 09:15:20 | 0 0 | 0 | Form 4 |
Washer Susan B. President and CEO | 2022-12-01 09:14:57 | 0 0 | 0 | Form 4 |
GUYER DAVID R Director | 2014-07-07 12:10:05 | 0 0 | 0 | Form 3 |
GLAXOSMITHKLINE PLC Former 10% Owner | 2020-02-14 16:38:03 | 0 0 | 0 | Form 13D |